FI120259B - Menetelmä epoksidin valmistamiseksi - Google Patents
Menetelmä epoksidin valmistamiseksi Download PDFInfo
- Publication number
- FI120259B FI120259B FI963452A FI963452A FI120259B FI 120259 B FI120259 B FI 120259B FI 963452 A FI963452 A FI 963452A FI 963452 A FI963452 A FI 963452A FI 120259 B FI120259 B FI 120259B
- Authority
- FI
- Finland
- Prior art keywords
- allyl
- formula
- acetonide
- epoxide
- equivalent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20607494A | 1994-03-04 | 1994-03-04 | |
US20607494 | 1994-03-04 | ||
PCT/US1995/002347 WO1995023797A1 (fr) | 1994-03-04 | 1995-02-27 | Procede de fabrication d'un epoxyde |
US9502347 | 1995-02-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI963452A0 FI963452A0 (fi) | 1996-09-03 |
FI963452A FI963452A (fi) | 1996-09-03 |
FI120259B true FI120259B (fi) | 2009-08-31 |
Family
ID=22764868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI963452A FI120259B (fi) | 1994-03-04 | 1996-09-03 | Menetelmä epoksidin valmistamiseksi |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0748319B1 (fr) |
JP (1) | JP3871705B2 (fr) |
KR (1) | KR100387741B1 (fr) |
CN (1) | CN1066728C (fr) |
AT (1) | ATE210662T1 (fr) |
AU (1) | AU690231B2 (fr) |
BR (1) | BR9506977A (fr) |
CA (1) | CA2183976C (fr) |
CZ (1) | CZ291816B6 (fr) |
DE (1) | DE69524578T2 (fr) |
DK (1) | DK0748319T3 (fr) |
ES (1) | ES2167419T3 (fr) |
FI (1) | FI120259B (fr) |
HR (1) | HRP950096B1 (fr) |
HU (1) | HU222750B1 (fr) |
MX (1) | MX9603871A (fr) |
NZ (1) | NZ281866A (fr) |
PT (1) | PT748319E (fr) |
RO (1) | RO117696B1 (fr) |
RU (1) | RU2137769C1 (fr) |
SK (1) | SK283067B6 (fr) |
TW (1) | TW380137B (fr) |
UA (1) | UA45968C2 (fr) |
WO (1) | WO1995023797A1 (fr) |
YU (1) | YU49010B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728840A (en) * | 1994-03-04 | 1998-03-17 | Merck & Co., Inc. | Process for making an epoxide |
TW415948B (en) * | 1995-10-30 | 2000-12-21 | Merck & Co Inc | Process for synthesizing epoxide and halohydrin |
US5981759A (en) * | 1997-06-20 | 1999-11-09 | Merck & Co., Inc. | Process for indinavir intermediate |
PL1948678T3 (pl) | 2005-11-09 | 2013-09-30 | Onyx Therapeutics Inc | Związki do hamowania enzymów |
DK2041158T3 (da) | 2006-06-19 | 2013-06-24 | Onyx Therapeutics Inc | Peptid-epoxidketoner til proteasom inhibering |
KR20150131405A (ko) | 2007-10-04 | 2015-11-24 | 오닉스 세라퓨틱스, 인크. | 결정형 펩티드 에폭시 케톤 프로테아제 저해제 및 아미노산 케토-에폭시드의 합성 |
EP2349313A4 (fr) | 2008-10-21 | 2012-08-29 | Onyx Therapeutics Inc | Thérapie de combinaison avec des peptides époxycétones |
AR075899A1 (es) | 2009-03-20 | 2011-05-04 | Onyx Therapeutics Inc | Tripeptidos epoxicetonas cristalinos inhibidores de proteasa |
US8853147B2 (en) | 2009-11-13 | 2014-10-07 | Onyx Therapeutics, Inc. | Use of peptide epoxyketones for metastasis suppression |
MX2012010017A (es) | 2010-03-01 | 2012-10-01 | Onyx Therapeutics Inc | Compuestos de para la inhibicion de inmunoproteasomas. |
CN103025730A (zh) * | 2010-04-30 | 2013-04-03 | 印第安纳大学研究及科技有限公司 | 制备利奈唑胺的方法 |
US20140105921A1 (en) | 2012-07-09 | 2014-04-17 | Onyx Therapeutics, Inc. | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors |
CN104692987B (zh) * | 2015-01-22 | 2017-05-17 | 北京大学 | 卤代醇及其衍生物的廉价高效合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2072237A1 (fr) * | 1991-07-02 | 1993-01-03 | Merck & Co., Inc. | Production stereoselective de composes hydroxyamide obtenus a partir d'-aminoepoxydes chiraux |
DK0541168T3 (da) * | 1991-11-08 | 1998-05-11 | Merck & Co Inc | HIV-proteaseinhibitorer, som er egnede til behandling af AIDS |
-
1995
- 1995-02-24 TW TW084101733A patent/TW380137B/zh not_active IP Right Cessation
- 1995-02-27 WO PCT/US1995/002347 patent/WO1995023797A1/fr active IP Right Grant
- 1995-02-27 ES ES95911105T patent/ES2167419T3/es not_active Expired - Lifetime
- 1995-02-27 AT AT95911105T patent/ATE210662T1/de active
- 1995-02-27 DK DK95911105T patent/DK0748319T3/da active
- 1995-02-27 JP JP52294995A patent/JP3871705B2/ja not_active Expired - Fee Related
- 1995-02-27 MX MX9603871A patent/MX9603871A/es unknown
- 1995-02-27 HU HU9602412A patent/HU222750B1/hu not_active IP Right Cessation
- 1995-02-27 CA CA002183976A patent/CA2183976C/fr not_active Expired - Fee Related
- 1995-02-27 NZ NZ281866A patent/NZ281866A/en not_active IP Right Cessation
- 1995-02-27 CZ CZ19962543A patent/CZ291816B6/cs not_active IP Right Cessation
- 1995-02-27 UA UA96103798A patent/UA45968C2/uk unknown
- 1995-02-27 PT PT95911105T patent/PT748319E/pt unknown
- 1995-02-27 EP EP95911105A patent/EP0748319B1/fr not_active Expired - Lifetime
- 1995-02-27 DE DE69524578T patent/DE69524578T2/de not_active Expired - Lifetime
- 1995-02-27 KR KR1019960704836A patent/KR100387741B1/ko not_active IP Right Cessation
- 1995-02-27 SK SK1122-96A patent/SK283067B6/sk not_active IP Right Cessation
- 1995-02-27 BR BR9506977A patent/BR9506977A/pt not_active IP Right Cessation
- 1995-02-27 RO RO96-01750A patent/RO117696B1/ro unknown
- 1995-02-27 CN CN95192714A patent/CN1066728C/zh not_active Expired - Lifetime
- 1995-02-27 AU AU18828/95A patent/AU690231B2/en not_active Ceased
- 1995-02-27 RU RU96120179A patent/RU2137769C1/ru not_active IP Right Cessation
- 1995-03-02 HR HR950096A patent/HRP950096B1/xx not_active IP Right Cessation
- 1995-03-03 YU YU14595A patent/YU49010B/sh unknown
-
1996
- 1996-09-03 FI FI963452A patent/FI120259B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108718527B (zh) | 用于制备化合物的方法 | |
US20120283434A1 (en) | Process for the preparation of rivaroxaban and intermediates thereof | |
FI120259B (fi) | Menetelmä epoksidin valmistamiseksi | |
EP3152191B1 (fr) | Procédé amélioré de production de promédicaments à base de duocarmycine | |
WO2022214645A1 (fr) | Procédés et intermédiaires pour la préparation de rélugolix | |
AU676079B2 (en) | Process for making HIV protease inhibitors | |
EP0708763B1 (fr) | Procede de preparation d'inhibiteurs de protease de vih | |
AU681499B2 (en) | Regiospecific process to make cis-1-amino-2-alkanol from epoxide | |
DE69813886T2 (de) | Naphthalin derivate | |
US5728840A (en) | Process for making an epoxide | |
CZ266196A3 (cs) | Regioselektivní způsob výroby cis-1-amino-2-indanolu | |
Kato et al. | Synthesis of 6‐amino‐1‐benzyl‐4‐methylhexahydro‐1H‐1, 4‐diazepine | |
JP2014125458A (ja) | 光学活性ベンズアミド誘導体の製造方法 | |
CA2167183C (fr) | Methode pour l'obtention d'inhibiteurs de la protease du vih | |
KR100393744B1 (ko) | 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1h-이미다졸-1-일)메틸]-4h-카바졸-4-온의 제조방법 | |
KR20020081771A (ko) | 신규의 아지리딘 유도체 및 그 제조방법 | |
ITMI20011435A1 (it) | Procedimento per la produzione di benzossazine e nuove benzossasine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 120259 Country of ref document: FI |
|
PC | Transfer of assignment of patent |
Owner name: MERCK SHARP & DOHME CORP. Free format text: MERCK SHARP & DOHME CORP. |
|
MM | Patent lapsed |